Whatman buys struggling HemaSure for $25 million
This article was originally published in Clinica
Executive Summary
UK analytical and healthcare company Whatman has solidified its link with troubled HemaSure by making an offer to acquire substantially all its assets. The deal, which is subject to shareholder approval, will see Whatman pay $10 million in cash upfront for the fixed assets and inventory of blood filtration company HemaSure.